Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Other

15 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Basic Science

Other

VICCHEM99009

10/01/2011

Evaluation of the impact of Human Papilloma Virus (HPV) in squamous cell skin cancer in Chronic Lymphocytic Leukemia (CLL) and Indolent Lymphoma (IL)

Basic Science

Miscellaneous

VICCBIO0478

03/31/2004

Donating Tissues for Research

Diagnostic

Lung
Miscellaneous

VICCTHO1078

04/12/2011

Nashville Early Diagnosis Lung Cancer Project

Diagnostic

Other

VICCDERM99013

01/01/2009

Noninvasive Detection of Skin Cancers Using Optical Spectroscopy; A Pilot In-Vivo Study

Diagnostic

Other

VICCGYN99011

04/13/2001

Detection of Cervical Precancers Using Near Infrared Raman Spectroscopy: A Pilot In Vivo Study

Other

Miscellaneous

VICCMD1494

10/31/2014

Specimen Collection under Clinical Protocol 06-C-0213 for Generation of Patient-Derived Models

Other

Miscellaneous

VICCPED0710

03/16/2007

Long Term Effects for Childhood Cancer Survivors

Prevention

Other

CTSUHNE1311-M

09/03/2013

A Randomized, Placebo Controlled Phase II Trial of Afatinib (BIBW2992) as Adjuvant Therapy Following Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma at High Risk of Recurrence

Supportive Care

Other

VICCURO99007

03/24/2014

A Pilot Study of Perioperative Oral Nutrition Supplementation to Improve Nutritional Status and Clinical Outcomes in Patients Undergoing Radical Cystectomy

Treatment

Other

CTSUBREA011106-M

11/21/2014

BRE A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: a phase III study

Treatment

Other

INCBBRE268-M

11/21/2014

INCB 18424-268 A Randomized, Double-Blind, Phase 2 Study of Ruxolitinib or Placebo in Combination with Capecitabine in Subjects with Advanced or Metastatic HER2-negative Breast Cancer (

Treatment

Other

ECOGLEUE1912-M

11/10/2014

A Randomized Phase III Study of Ibrutinib(PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL).

Treatment

Other

ECOGTHO2511-M

11/04/2014

Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination with Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer

Treatment

Other

VICCNCPED1414

04/24/2014

HLA-haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and other Nonmalignant Disorders Using Conditioning with Low-Dose Cyclophosphamide, TBI and Fludarabine; Postgrafting Immunosuppression will Consist of a Single Low Dose of Cyclophosphamide, MMF and Tacrolimus

Treatment

Other

CTSUMM1A11-M

02/12/2014

MM E1A11: Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)